Recent news
Subscribe to Southwest Michigan Innovation Center's RSS feed.
Posted by Western Michigan University News on January 30, 2012:
By Cheryl Roland
KALAMAZOO--A financial professional with an extensive background in helping to launch startup companies will take the reins of Western Michigan University's Biosciences Research and Commercialization Center.
Stephen J. Haakenson has been named executive director of the BRCC, effective Feb ... Read more
Posted by Southwest Michigan Innovation Center on January 12, 2012:
By Yvonne Zipp
KALAMAZOO — In a move that could help Kalamazoo strengthen its base as a life sciences center, the Southwest Michigan Innovation Center has been awarded a $600,000 grant from the Michigan Strategic Fund.
The 2012 Business Incubator Grant, which was the fourth-largest awarded, was part of $6 million given to a dozen incubators across the state by the Michigan Economic Development Council in Lansing ... Read more
Posted by MEDCITY News on January 6, 2012:
By Deanna Pogorelc for MEDCITY News
Cleveland Clinic spinoff Tolera Therapeutics is more than halfway to its goal of a $1.65 million round of financing for its immunomodulation therapy for organ transplant.
Cofounded by Dr. Maria Siemionow, the leader of the Cleveland Clinic surgery team that performed the nation’s first near-total face transplant in 2008, Tolera is developing a drug intended to suppress the immune system of patients receiving organ transplants in order to prevent organ rejection ... Read more
Posted by MEDC on December 21, 2011:
By Michael Shore
LANSING – The Michigan Economic Development Corporation (MEDC) announced that the Michigan Strategic Fund is supporting entrepreneurs’ efforts to launch and grow start-up companies throughout the state with funding for high-performance business incubators and accelerators in Michigan ... Read more
Posted by The Grand Rapids Press on December 16, 2011:
By Garret Ellison for The Grand Rapids Press
GRAND RAPIDS — When it became apparent that Intervention Insights software under development at the Van Andel Research Institute that matches cancer patients with personalized drug regimens was ready for the market, the call went out for investment capital ... Read more